BRIEF published on 11/04/2025 at 15:51, 11 months 5 days ago Le groupe Vanguard révèle sa participation dans Mural Oncology plc Le Groupe Vanguard Formulaire 8.3 Mural Oncology Plc Panel Irlandais Des OPA Déclaration Relative À L'actionnariat
PRESS RELEASE published on 11/04/2025 at 15:51, 11 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 7.47% ownership in American Axle & Manufacturing Holdings, Inc. Form 8.3 submitted on 04-Nov-2025 Form 8.3 Vanguard Group Ownership Disclosure Financial Disclosure American Axle
BRIEF published on 11/04/2025 at 15:50, 11 months 5 days ago The Vanguard Group's Interest in Greencore Group plc The Vanguard Group Stake Disclosure Stock Transactions Investment Transparency Greencore Group Plc
BRIEF published on 11/04/2025 at 15:50, 11 months 5 days ago L'intérêt du groupe Vanguard pour Greencore Group plc Transactions Boursières Le Groupe Vanguard Transparence Des Investissements Greencore Group Plc Déclaration Des Participations
PRESS RELEASE published on 11/04/2025 at 15:49, 11 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.05% stake in JTC plc. Position disclosure under Rule 8.3 of the Takeover Code Disclosure Takeover Code Vanguard Group Stake JTC Plc
PRESS RELEASE published on 11/04/2025 at 15:48, 11 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.67% interest in Avadel Pharmaceuticals plc on 03 November 2025 The Vanguard Group, Inc. Irish Takeover Panel Interest Disclosure Stock Holdings Avadel Pharmaceuticals Plc
BRIEF published on 11/04/2025 at 15:48, 11 months 5 days ago Vanguard Discloses Position in Spire Healthcare Securities Form 8.3 Takeover Code Spire Healthcare Vanguard
BRIEF published on 11/04/2025 at 15:48, 11 months 5 days ago Vanguard révèle sa participation dans Spire Healthcare Spire Healthcare Titres Code De Prise De Contrôle Formulaire 8.3 Avant-garde
PRESS RELEASE published on 11/04/2025 at 15:46, 11 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses 1.67% ownership in Mural Oncology plc. No other party disclosures made. Details on Form 8.3 The Vanguard Group, Inc. Form 8.3 Ownership Disclosure Financial Disclosure Mural Oncology Plc
BRIEF published on 11/04/2025 at 15:46, 11 months 5 days ago The Vanguard Group Discloses Position in Alphawave IP Group Form 8.3 Takeover Code Vanguard Group Stock Disclosure Alphawave IP
Published on 10/09/2026 at 14:00, 4 hours 9 minutes ago Stillwater Critical Minerals Upgrades to OTCQX Best Market, Expanding U.S. Market Presence
Published on 10/09/2026 at 14:00, 4 hours 9 minutes ago Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Published on 10/09/2026 at 13:23, 4 hours 46 minutes ago SLAM Exploration Announces Leadership Transition and Appointment of Jimmy Gravel as President and CEO
Published on 10/09/2026 at 13:00, 5 hours 9 minutes ago Horizon Aircraft Reports Fiscal 2027 First Quarter Results and Advances Full-Scale Cavorite X7 Development
Published on 10/09/2026 at 13:00, 5 hours 9 minutes ago Nepra Foods Launches Flagship PROPASTA Brand on Amazon
Published on 10/09/2026 at 17:15, 54 minutes ago OPPO Find X10 Pro Max to Debut Globally with MediaTek’s 2nm Flagship Dimensity 9600 Pro
Published on 10/09/2026 at 17:10, 59 minutes ago "Soaring Creativity - Hong Kong Pavilion" Returns to Frankfurt Book Fair 2026, Showcasing Over 1,000 Masterpieces
Published on 10/09/2026 at 16:30, 1 hour 39 minutes ago Novem Group S.A.: Changes in Management Board
Published on 10/09/2026 at 15:55, 2 hours 14 minutes ago Bio-Gate AG reports first half results for 2026
Published on 10/09/2026 at 15:53, 2 hours 16 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/09/2026 at 17:45, 24 minutes ago COGRA : CHIFFRE D’AFFAIRES DU 1er TRIMESTRE 2026/27 10,5 M€ - Une activité solide à l’approche de la saison de chauffe
